Doctolib has acquired London-based Medicus and plans to invest more than £100 million in the UK, including hiring 150 people and establishing a London R&D centre. Medicus's own announcement describes joining forces with Doctolib to support the future of NHS primary care. HTN reports the deal as a move to bring AI tools and digital workflows to GP practices across the UK.
The UK GP IT layer is becoming strategically valuable again. Whoever controls the primary-care workflow — the clinical system where appointments, consultations, documentation, prescribing, referrals, and coding converge — can embed AI into every clinical moment.
What Happened
Doctolib — Europe's largest digital health platform, serving 520,000 health professionals and 90 million people across France, Germany, and Italy — has acquired Medicus, the first new core GP IT system approved by NHS England in 25 years. Medicus was approved through NHS England's Tech Innovation Framework in June 2025, integrating with 24 national NHS services including EPS, eRS, NHS App, PDS, and SCR.
By March 2026, Medicus was live in 10 GP practices with 97 planned across 18 ICB areas. The acquisition gives Doctolib regulatory-cleared access to UK primary care infrastructure — the difficult asset in UK healthtech.
Why This Matters for Primary Care
GP IT duopoly pressure. EMIS and SystmOne have dominated for decades. NHS England explicitly framed Medicus's approval as reforms to increase competition. Doctolib brings European scale, capital, and product experience to challenge the status quo.
Workflow control. The GP clinical system is not just a record — it is the appointment book, prescribing route, referral interface, coding system, and medico-legal memory. AI embedded within this system has structural advantages over standalone tools.
AI documentation integration. Doctolib has acquired Aaron.ai (AI telephone reception) and Typeless (speech-to-structured text). Combined with Medicus, the components of an AI-enabled clinical operating system are assembling.
The Opportunity and Risk
Opportunity: better tools, more competition, faster workflows, modern cloud infrastructure replacing legacy systems.
Risk: AI embedded too deeply within one vendor's platform without transparent clinical knowledge provenance. If the evidence layer is bundled inside the EHR, clinicians may lose the ability to independently verify answers, compare sources, and choose their own clinical knowledge tools.
Where iatroX Fits
If GP systems become AI platforms, clinicians will still need trusted, source-verifiable clinical knowledge. iatroX can sit as a professional knowledge layer: Ask iatroX for guideline-grounded answers, calculators for structured assessment, Q-banks for professional learning, and CPD for reflective practice — independent of any EHR vendor, portable across systems.
The future GP workflow may not be one AI product. It may be an ecosystem: access triage, EHR, scribe, clinical search, prescribing support, and CPD.
Use iatroX as the UK clinical knowledge layer alongside the evolving GP workflow →